TY - JOUR
T1 - Coupling Microscopy and Flow Cytometry for a Comprehensive Characterization of Nanoparticle Production in Insect Cells
AU - Puente-Massaguer, Eduard
AU - Saccardo, Paolo
AU - Ferrer-Miralles, Neus
AU - Lecina, Martí
AU - Gòdia, Francesc
N1 - Funding Information:
The authors would like to thank Marta Martínez‐Calle for developing the BV‐Gag‐eGFP. We would also like to thank Nick Berrow (Institute for Research in Biomedicine, Barcelona, Spain), Paula Alves (Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal), and Julià Blanco (Irsi Caixa, Badalona, Spain) for providing the Sf9 cells, the High Five cell line and the pGag‐eGFP plasmid, respectively. We also appreciate the collaboration of Jorge Fomaro and Ángel Calvache (Beckman Coulter) in ceding the CytoFlex LX flow cytometer and Irene González‐Domínguez from Universitat Autònoma de Barcelona (UAB) for discussion with flow virometry data. The technical support of Mónica Roldán from Servei de Microscòpia (UAB) and Servei d'Anatomia Patològica (Hospital Sant Joan de Déu, Barcelona, Spain) with TCS SP5 and SP8 confocal microscopes, respectively, is acknowledged. Martí de Cabo from Servei de Microscòpia (UAB) provided support with cryo‐TEM analyses and Katrin Reiter (University of Natural Resources and Life Sciences, Vienna, Austria) with SDS‐PAGE and Western Blot. The advice of Manuela Costa (Servei de Cultius Cel·lulars, Producció d'Anticossos i Citometria, UAB) with flow cytometry and José Amable Bernabé (Institut de Ciència de Materials de Barcelona, CSIC) with NTA is recognized. The support from the ICTS “NANBIOSIS,” more specifically by the Protein Production Platform of CIBER in Bioengineering, Biomaterials and Nanomedicine (CIBER‐BBN)/IBB, at the UAB SePBioEs scientific‐technical service ( www.nanbiosis.es ) is also acknowledged. Eduard Puente‐Massaguer is a recipient of an FPU grant from Ministerio de Educación, Cultura y Deporte of Spain (FPU15/03577). The research group is recognized as 2017 SGR 898 by Generalitat de Catalunya.
Funding Information:
The authors would like to thank Marta Mart?nez-Calle for developing the BV-Gag-eGFP. We would also like to thank Nick Berrow (Institute for Research in Biomedicine, Barcelona, Spain), Paula Alves (Instituto de Biologia Experimental e Tecnol?gica, Oeiras, Portugal), and Juli? Blanco (Irsi Caixa, Badalona, Spain) for providing the Sf9 cells, the High Five cell line and the pGag-eGFP plasmid, respectively. We also appreciate the collaboration of Jorge Fomaro and ?ngel Calvache (Beckman Coulter) in ceding the CytoFlex LX flow cytometer and Irene Gonz?lez-Dom?nguez from Universitat Aut?noma de Barcelona (UAB) for discussion with flow virometry data. The technical support of M?nica Rold?n from Servei de Microsc?pia (UAB) and Servei d'Anatomia Patol?gica (Hospital Sant Joan de D?u, Barcelona, Spain) with TCS SP5 and SP8 confocal microscopes, respectively, is acknowledged. Mart? de Cabo from Servei de Microsc?pia (UAB) provided support with cryo-TEM analyses and Katrin Reiter (University of Natural Resources and Life Sciences, Vienna, Austria) with SDS-PAGE and Western Blot. The advice of Manuela Costa (Servei de Cultius Cel?lulars, Producci? d'Anticossos i Citometria, UAB) with flow cytometry and Jos? Amable Bernab? (Institut de Ci?ncia de Materials de Barcelona, CSIC) with NTA is recognized. The support from the ICTS ?NANBIOSIS,? more specifically by the Protein Production Platform of CIBER in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN)/IBB, at the UAB SePBioEs scientific-technical service (www.nanbiosis.es) is also acknowledged. Eduard Puente-Massaguer is a recipient of an FPU grant from Ministerio de Educaci?n, Cultura y Deporte of Spain (FPU15/03577). The research group is recognized as 2017 SGR 898 by Generalitat de Catalunya.
Publisher Copyright:
© 2020 International Society for Advancement of Cytometry
PY - 2020/9/1
Y1 - 2020/9/1
N2 - Advancements in the field of characterization techniques have broadened the opportunities to deepen into nanoparticle production bioprocesses. Gag-based virus-like particles (VLPs) have shown their potential as candidates for recombinant vaccine development. However, comprehensive characterization of the production process is still a requirement to meet the desired critical quality attributes. In this work, the production process of Gag VLPs by baculovirus (BV) infection in the reference High Five and Sf9 insect cell lines is characterized in detail. To this end, the Gag polyprotein was fused in frame to the enhanced green fluorescent protein (eGFP) to favor process evaluation with multiple analytical tools. Tracking of the infection process using confocal microscopy and flow cytometry revealed a pronounced increase in the complexity of High Five over Sf9 cells. Cryogenic transmission electron microscopy (cryo-TEM) characterization determined that changes in cell complexity could be attributed to the presence of occlusion-derived BV in High Five cells, whereas Sf9 cells evidenced a larger proportion of the budded virus phenotype (23-fold). Initial evaluation of the VLP production process using spectrofluorometry showed that higher levels of the Gag-eGFP polyprotein were obtained in High Five cells (3.6-fold). However, comparative analysis based on nanoparticle quantification by flow virometry and nanoparticle tracking analysis (NTA) proved that Sf9 cells were 1.7- and 1.5-fold more productive in terms of assembled VLPs, respectively. Finally, analytical ultracentrifugation coupled to flow virometry evidenced a larger sedimentation coefficient of High Five-derived VLPs, indicating a possible interaction with other cellular compounds. Taken together, these results highlight the combined use of microscopy and flow cytometry techniques to improve vaccine development processes using the insect cell/BV expression vector system.
AB - Advancements in the field of characterization techniques have broadened the opportunities to deepen into nanoparticle production bioprocesses. Gag-based virus-like particles (VLPs) have shown their potential as candidates for recombinant vaccine development. However, comprehensive characterization of the production process is still a requirement to meet the desired critical quality attributes. In this work, the production process of Gag VLPs by baculovirus (BV) infection in the reference High Five and Sf9 insect cell lines is characterized in detail. To this end, the Gag polyprotein was fused in frame to the enhanced green fluorescent protein (eGFP) to favor process evaluation with multiple analytical tools. Tracking of the infection process using confocal microscopy and flow cytometry revealed a pronounced increase in the complexity of High Five over Sf9 cells. Cryogenic transmission electron microscopy (cryo-TEM) characterization determined that changes in cell complexity could be attributed to the presence of occlusion-derived BV in High Five cells, whereas Sf9 cells evidenced a larger proportion of the budded virus phenotype (23-fold). Initial evaluation of the VLP production process using spectrofluorometry showed that higher levels of the Gag-eGFP polyprotein were obtained in High Five cells (3.6-fold). However, comparative analysis based on nanoparticle quantification by flow virometry and nanoparticle tracking analysis (NTA) proved that Sf9 cells were 1.7- and 1.5-fold more productive in terms of assembled VLPs, respectively. Finally, analytical ultracentrifugation coupled to flow virometry evidenced a larger sedimentation coefficient of High Five-derived VLPs, indicating a possible interaction with other cellular compounds. Taken together, these results highlight the combined use of microscopy and flow cytometry techniques to improve vaccine development processes using the insect cell/BV expression vector system.
KW - baculovirus
KW - cryo-TEM
KW - flow cytometry
KW - flow virometry
KW - occlusion-derived virus
KW - virus-like particle
UR - http://www.scopus.com/inward/record.url?scp=85086014098&partnerID=8YFLogxK
U2 - 10.1002/cyto.a.24033
DO - 10.1002/cyto.a.24033
M3 - Article
C2 - 32515126
AN - SCOPUS:85086014098
SN - 1552-4922
VL - 97
SP - 921
EP - 932
JO - Cytometry Part A
JF - Cytometry Part A
IS - 9
ER -